April 14, 2020 by Chain Drug Review
COVID-19, The Pharmacy Technician Certification Board (PTCB), William Schimmel
Pharmacy
WASHINGTON – The Pharmacy Technician Certification Board (PTCB), the nation’s leading certifying organization for pharmacy technicians, will soon offer online proctored exam delivery of the Pharmacy Technician Certification Exam (PTCE) during the coronavirus (COVID-19) pandemic. This test delivery option makes testing available for candidates seeking to earn their Certified Pharmacy Technician (CPhT) credential during COVID-19. Online
April 14, 2020 by Chain Drug Review
COVID-19, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, VA. — NACDS is distributing through national cable networks a video – titled “Rise” – that has been classified as a national public service announcement (PSA). The PSA aligns the resolve of the nation and the resolve of pharmacy in confronting and overcoming COVID-19. The PSA reflects on challenges faced by America in the past,
April 14, 2020 by Chain Drug Review
Andrew Stroup, COVID-19, Daniel Lubetzky, Project N95, The KIND Foundation
Supplier News
NEW YORK — The KIND Foundation and Project N95 have launched the Frontline Impact Project, a platform whereby healthcare institutions and other front line response organizations can request resources to help meet their greatest needs in the face of the COVID-19 pandemic. Furthering the work of Project N95, which to date has focused on performing supply chain diligence
April 14, 2020 by Chain Drug Review
COVID-19, Hy-Vee
Leading Headlines, Retail News
WEST DES MOINES, Iowa — As the coronavirus continues to impact daily lives, Hy-Vee is asking essential workers across its eight-state region to submit photos of themselves doing their jobs so Hy-Vee can recognize the work they are doing every day to serve their communities. The photos will be featured on Hy-Vee’s social media platforms
April 13, 2020 by Chain Drug Review
COVID-19, E.T. Browne Drug Co., Hayward Laboratories
Supplier News
ENGLEWOOD CLIFFS, N.J.— E.T. Browne Drug Co., manufacturer of Palmer’s Cocoa Butter Formula and Coconut Oil Formula skin and hair care products, announced that its manufacturing facility, Hayward Laboratories, has started producing medical-grade hand sanitizer, to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanitizer will supply local medical first
April 13, 2020 by Chain Drug Review
COVID-19, LifeStyles, LifeStyles’ SKYN
Leading Headlines, Supplier News
ISELIN, N.J.— LifeStyles, a global leader in sexual protection solutions and the makers of LifeStyles and SKYN, has donated over 5,000 non-lubricated condoms to St Mary’s Passaic in Passaic N.J. to be used in lieu of traditional stethoscope covers. Due to extreme shortage and heightened need for protective equipment, emergency room doctors have reduced stethoscope usage
April 13, 2020 by Chain Drug Review
COVID-19, Rob Robinson, Tom's of Maine
Supplier News
KENNEBUNK, Maine — Across the country, Americans are adopting new routines to do their part to help keep communities safe. While staying at home and apart from one another, it can be challenging to forgo the activities that bring us relaxation and peace of mind such as enjoying nature. However, even when staying indoors, we
April 13, 2020 by Chain Drug Review
COVID-19, FRONTLINE, Tooling Tech Group (TTG)
Leading Headlines, Retail News, Supplier News
MACOMB, Mich. — Tooling Tech Group (TTG) has announced the availability of its FRONTLINE customized transparent barrier protection for quick installation at cash register stations or customer service counters. Appropriate for big box stores, grocery stores, pharmacies and more, these plexiglass barriers serve as a physical layer of protection between employees and patrons while enabling personal
April 13, 2020 by Chain Drug Review
Clint Mahlman, COVID-19, London Drugs, United Way
Featured Articles, Leading Headlines, Retail News
RICHMOND, B.C.– London Drugs is expanding its community support program launched a few weeks ago, to continue to help more seniors and vulnerable individuals who are self isolating. Starting in the Lower Mainland and Fraser Valley with potential expansion to more areas, a new collaboration with United Way connects ready and willing volunteers with vulnerable
April 10, 2020 by Chain Drug Review
COVID-19, Dearborn Market and Gourmet Garage. Stores, Joe Colalillo, Price Rite Marketplace, ShopRite, The Fresh Grocer, Wakefern Food Corp.
Leading Headlines, Retail News
KEASEBY, N.J. – To help protect its associates and shoppers, members of the retailer-owned supermarket cooperative, Wakefern Food Corp., have initiated its latest measure to enhance the safety of its customers and associates. Beginning next week, stores will implement a temperature monitoring program. As part of the initiative, stores will use Non-contact Forehead Infrared Thermometers to
April 10, 2020 by Chain Drug Review
COVID-19, hydroxychloroquine, Rick Niemi, Valor Compounding Pharmacy
Leading Headlines, Pharmacy
BERKELEY, Calif. — Valor Compounding Pharmacy has obtained hydroxychloroquine in an effort to offer continued treatment for patients with lupus, malaria, rheumatoid arthritis, and other medical applications. Valor developed a plan to reasonably dispense the medication so as not to jeopardize the needs of patients with chronic conditions. Valor recognized that this pharmaceutical ingredient would quickly be in high
April 9, 2020 by Chain Drug Review
COVID-19, CVS Pharamcy, George Coleman
Leading Headlines, Retail News
WOONSOCKET, R.I. – CVS Pharmacy announced Thursday it will donate more than $5 million worth of seasonal treats to local community organizations across the country to help families celebrate upcoming holidays, including Easter. Earlier this month, CVS also began surprising home prescription delivery and drive-thru customers with free spring-themed greeting cards. These efforts aim to
April 9, 2020 by Chain Drug Review
Avigan, COVID-19, Fujifilm Corp.
Pharmacy, Supplier News
TOKYO — Fujifilm announced the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan Tablet” for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus. Avigan, approved in Japan for manufacture and sale as an influenza antiviral drug, selectively inhibits RNA polymerase necessary for
April 9, 2020 by Chain Drug Review
CHPA, COVID-19, O-T-Cs, Scott Melville
Leading Headlines
WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented
